Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03665051 · ClinicalTrials.gov registry record

Electrical Stimulation of Human Myocytes in Microgravity

A clinical trial of Sarcopenia, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
75
Enrollment target
1
Study location

NCT03665051: Active study of Sarcopenia, sponsored by AdventHealth Translational Research Institute.

NCT03665051 is a study of Sarcopenia that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 75 participants, roughly in line with the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03665051, a study of Sarcopenia, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the changes of muscle, in microgravity. Which will help explain the health benefits of exercise. There are tests that can be done to tell researchers more about the human body, such as a dual energy x-ray absorptiometry (DEXA) scan, which measures body composition (fat and lean body mass). The use of muscle testing and a Handgrip test can tell us about the strength and power within an individual's muscles. A VO2 max test helps us understand the aerobic fitness level of an individual and one of the most important aspects of this study are muscle cells. A muscle biopsy allows us to obtain muscle cells from the thigh, which will be sent into space by a rocket. Researchers will study these muscle cells in a low gravity environment aboard the International Space Station. Studying the muscle cells under those conditions will potentially mimic an accelerated aging process, which will help researchers better understand muscle wasting in the elderly.

Primary Outcome

Collection of the muscle biopsy parameters (isolated satellite cells), from 9 participants in each of young and old study groups.

Conditions Studied

Interventions

  • PROCEDURE Muscle Tissue Biopsy
  • OTHER Maximal Oxygen Consumption (V02max)

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2019-01-25
Est. Completion 2025-12

What the registry record for NCT03665051 still lists

NCT03665051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, roughly in line with the 79-participant average among 41 other Sarcopenia trials with a reported enrollment target.

The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 2 interventions - of which Muscle Tissue Biopsy is the first listed.

NCT03665051 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03665051 about?

NCT03665051 is a clinical study titled "Electrical Stimulation of Human Myocytes in Microgravity". The purpose of this study is to evaluate the changes of muscle, in microgravity. Which will help explain the health benefits of exercise. There are tests that can be done to tell researchers more about the human body, such as a dual energy x-ray absorptiometry (DEXA) scan, which measures body compos...

What is the current status of trial NCT03665051?

This trial is currently active not recruiting. The enrollment target is 75 participants. The study started on 2019-01-25. Estimated completion is 2025-12.

What conditions does trial NCT03665051 study?

This clinical trial studies the following conditions: Sarcopenia.

What interventions are being tested in trial NCT03665051?

The interventions under investigation include: Muscle Tissue Biopsy (PROCEDURE), Maximal Oxygen Consumption (V02max) (OTHER).

Who is sponsoring clinical trial NCT03665051?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03665051 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03665051's enrollment target sits among peer trials

75 16th of 41 higher than 26 of 41 other Sarcopenia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03665051, the US trial registry maintained by the National Library of Medicine. NCT03665051 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.